What Happened?
, -based Scipher Medicine Appointed Kyla Pavlina as Chief People Officer, Interim
About the Company
Most patients who are prescribed blockbuster therapies today don`t respond to the treatment, costing the health care industry billions in wasted drugs while patients continue to suffer. Scipher`s platform identifies which drug will work based on the patient`s fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A simple test predicts which drug he/she will respond to, ensuring that most optimal treatment is prescribed from day one. The molecular data generated by our tests is then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.
About the Person
Kyla Pavlina is Chief People Officer, Interim at Scipher Medicine. Previously, Kyla held various senior HR leadership roles in the industry.
Info Source
News
Short Profile